Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/24/2015 08/25/2015 08/26/2015 08/27/2015 08/28/2015 Date
23.24(c) 23.94(c) 24.55(c) 27.92(c) 28.28(c) Last
1 363 122 610 619 1 000 099 1 706 732 1 546 221 Volume
-7.59% +3.01% +2.55% +13.73% +1.29% Change
More quotes
Financials ($)
Sales 2015 141 M
EBIT 2015 49,4 M
Net income 2015 35,4 M
Debt 2015 -
Yield 2015 -
Sales 2016 214 M
EBIT 2016 100 M
Net income 2016 42,4 M
Debt 2016 -
Yield 2016 -
PER 2015 37,09
PER 2016 31,08
Capi. / Sales 2015 9,08x
Capi. / Sales 2016 5,98x
Capitalization 1 280 M
More Financials
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company which engages in research, discovery, development and commercialization of proprietary drugs in the Americas, Europe and Asia.It is developing prostones, which are ion channel activators, to treat gastrointestinal, ophthalmic and... 
More about the company
Surperformance© ratings of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on SUCAMPO PHARMACEUTICALS, I
08/26 SUCAMPO PHARMACEUTICALS : Entry into a Material Definitive Agreement, Regulation..
08/26 Sucampo Launches Tender Offer to Acquire R-Tech Ueno
08/05 SUCAMPO PHARMACEUTICALS : Management's Discussion and Analysis of Financial Cond..
08/05 SUCAMPO PHARMACEUTICALS : posts 2Q profit
08/05 SUCAMPO PHARMACEUTICALS : Results of Operations and Financial Condition, Regulat..
08/05 Sucampo Reports Second Quarter 2015 Financial Results and Corporate Update
08/04 SUCAMPO PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
07/24 SUCAMPO PHARMACEUTICALS : Technical Report on Drug Manufacturers - Other Stocks ..
More news
Sector news : Bio Therapeutic Drugs
08/28 QUINTILES TRANSNATIONAL : CEO to Present at UBS Best of Americas 2015 Conference
08/27 INTREXON : Soligenix Receives Additional NIAID Funding to Advance Development of..
08/27 ACTELION : Additional data on selexipag (uptravi) and macitentan (opsumit) to be..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
08/28 PREMARKET BIOTECH DIGEST : Geron EDP Today, Repatha Approval, Mylan Perrigo Deal
08/06 PREMARKET BIOTECH DIGEST PART 2 : My Top Biopicks 2015 Performance, Anavex Bigge..
08/05 Sucampo Pharmaceutical's (SCMP) Peter Greenleaf on Q2 2015 Results - Earnings..
08/05 Sucampo Pharmaceuticals (SCMP) Q2 2015 Results - Earnings Call Webcast
08/05 Sucampo beats by $0.06, beats on revenue


Comments 
Advertisement
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Technical analysis trends SUCAMPO PHARMACEU...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions